Blog post - 5 February 2012 17:34

Leicestershire Parents Group of Diabetes UK

Yesterday John and I traveled from London to Loughborough in Leicestershire county to share news of Timesulin with the parents group there. John also gave a talk on his experiences as someone who has lived with Type 1 for over 26 years. It was such an honour to be invited to attend this event where over 150 people came with one thing in common...a wish to learn more about managing diabetes and making life for those living with it a little easier.

Also at the event was the racecar driver Paul O'Neill who was diagnosed with Type 1 about eight years ago. What a great guy! Despite his Type 1 diagnosis, Paul is one of Britain's best on the car racing scene. Paul is now using Timesulin smart caps on his Lantus and NovoRapid insulin pens and has promised us some feedback, which I'll share with you soon.

Topics

Diseases

Contacts

John Sjölund

Press contact CEO & Co-founder Sales and distribution, company spokesperson john@timesulin.com +44 (0)20 3287 2760 Timesulin Spokespeople

Marie Rönn

Press contact Marketing Manager Account Management and Marketing marie@timesulin.com +46 (0) 733 311 722

Related media

Timesulin smart cap for Sanofi-Aventis Solostar
License: Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
By: Timesulin / www.timesulin.com

Timesulin smart cap for Lilly Kwikpen
License: Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
By: Timesulin / www.timesulin.com

Timesulin smart cap for Novo Nordisk Flexpen
License: Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
By: Timesulin / www.timesulin.com

Type 1: John Sjölund and Paul O'Neill
License: Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
By: Timesulin / www.timesulin.com

New Smart Cap ‘Timesulin’ Offers Major Advance in Diabetes Compliance

Innovative solution that shows insulin-dependent patients how long it’s been since their last injection, launches to consumers across Europe today.

5 December 2011 10:33

Timely relief for insulin-dependent people with diabetes showcasing at global diabetes congress

A new product in the management of insulin-dependent diabetes, launching to consumers in Europe in January 2012, offers patients significant relief through an incorporated timer that tells them how long it’s been since their last insulin injection.